The FDA has accepted a Biologics License Application for imsidolimab to treat generalized pustular psoriasis, a rare inflammatory skin condition.

Family peanut consumption was associated with peanut allergy in younger siblings, though early dietary introduction helped overcome this risk.

Transgender men have a higher acne risk compared with matched cisgender men and women, with the risk highest at 1 year after testosterone initiation.

Risankizumab is effective through 2.5 years of treatment among patients with psoriasis, with most patients achieving rapid and sustained response.

Though the decision on elimination status has been postponed, the timeline to be considered is unchanged. Officials will determine whether transmission continues for a full year after the start of the ...

HealthDay News — For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, ...